Publications by authors named "Jorda M"

Castration-resistant prostate cancer (CRPC) is incurable and fatal, making prostate cancer the second leading cancer-related cause of death for American men. CRPC results from therapeutic resistance to standard-of-care androgen deprivation (AD) treatments, through incompletely understood molecular mechanisms, and lacks durable therapeutic options. In this study, we identified enhanced soluble guanylyl cyclase (sGC) signaling as a mechanism that restrains CRPC initiation and growth.

View Article and Find Full Text PDF

Urine cytology is a non-invasive, cost-efficient, and sensitive test to detect high-grade urothelial carcinoma. The Paris System (TPS) for Reporting Urinary Cytology is an evidence-based system that uses the risk of malignancy to guide patient management. Since its inception, TPS has standardized urine cytology reports, facilitating communication among pathologists and between pathologists and clinicians.

View Article and Find Full Text PDF

Context: Medical treatment of acromegaly is currently performed through a trial-and-error approach using first-generation somatostatin receptor ligands (fgSRLs) as first-line drugs, with an effectiveness of about 50%, and subsequent drugs are indicated through clinical judgment. Some biomarkers can predict fgSRLs response.

Objective: Here we report the results of the ACROFAST study, a clinical trial in which a protocol based on predictive biomarkers of fgSRLs was evaluated.

View Article and Find Full Text PDF

Introduction: Growth hormone (GH)-secreting pituitary tumors (GHomas) are the most common acromegaly cause. At diagnosis, most of them are macroadenomas, and up to 56% display cavernous sinus invasion. Biomarker assessment associated with tumor growth and invasion is important to optimize their management.

View Article and Find Full Text PDF
Article Synopsis
  • - The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) suggests that atypia of undetermined significance (AUS) should not exceed 10%, but some recent findings indicate that it might often be overused, especially when molecular testing results are low.
  • - A study analyzed the cytology cases over 4.5 years, examining AUS rates and positive call rates for different cytopathologists, revealing a wide range of AUS rates (from 9.9% to 36.8%) and an overall positive call rate of 24%.
  • - The findings suggest that monitoring AUS rates alongside positive call rates can provide a valuable way to evaluate and enhance the performance of cytology labs and individual cytopath
View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on the use of the atypia of undetermined significance (AUS) category in thyroid evaluations, emphasizing the need to keep the AUS rate at or below 10% to enhance diagnostic quality and minimize variability.
  • - Researchers analyzed 2,248 thyroid aspirates, calculating the AUS:Malignant (AUS:M) ratio, ThyroSeq v3 positive call rate (PCR), molecular-derived risk of malignancy (MDROM), and overall risk of malignancy (ROM) across different cytopathologists (CPs).
  • - Results showed a moderate correlation between AUS:M ratios and TSV3 PCR/MDROM, highlighting the value of multiple metrics for assessing diagnostic performance and tailoring feedback for each cytopath
View Article and Find Full Text PDF

Objectives: There are 2 grading approaches to radical prostatectomy (RP) in multifocal cancer: Grade Group (GG) and percentage of Gleason pattern 4 (GP4%). We investigated whether RP GG and GP4% generated by global vs individual tumor grading correlate differently with biochemical recurrence.

Methods: We reviewed 531 RP specimens with GG2 or GG3 cancer.

View Article and Find Full Text PDF

Precision, personalized, or individualized medicine in pituitary neuroendocrine tumors (PitNETs) has become a major topic in the last few years. It is based on the use of biomarkers that predictively segregate patients and give answers to clinically relevant questions that help us in the individualization of their management. It allows us to make early diagnosis, predict response to medical treatments, predict surgical outcomes and investigate new targets for therapeutic molecules.

View Article and Find Full Text PDF

Context.—: Metastatic pleomorphic lobular carcinoma (MPLC) to the bladder is rare and has considerable histologic and immunohistochemical overlap with plasmacytoid urothelial carcinoma (PUC).

Objective.

View Article and Find Full Text PDF

Context.—: Retraction artifact, paradoxic maturation/differentiation, desmoplasia, and complex irregular growth are morphologic criteria of invasion in urothelial carcinoma.

Objective.

View Article and Find Full Text PDF

Background And Aims: Predictors of first-generation somatostatin receptor ligands (fgSRLs) response in acromegaly have been studied for over 30 years, but they are still not recommended in clinical guidelines. Is there not enough evidence to support their use? This systematic review aims to describe the current knowledge of the main predictors of fgSRLs response and discuss their current usefulness, as well as future research directions.

Methods: A systematic search was performed in the Scopus and PubMed databases for functional, imaging, and molecular predictive factors.

View Article and Find Full Text PDF
Article Synopsis
  • A short version of the acute octreotide test (sAOT) was re-evaluated to predict responses to somatostatin receptor ligands (SRLs) in acromegaly patients, utilizing ultra-sensitive growth hormone (GH) assays.
  • In a study of 47 patients, the results showed that 30 were responders and 17 were non-responders, with specific GH levels serving as predictive cutoffs for treatment responses.
  • The study found that patients with E-cadherin-positive tumors had lower GH levels and higher somatostatin receptor 2 (SSTR2) scores, indicating that sAOT can aid in clinical treatment decisions based on tumor characteristics.
View Article and Find Full Text PDF

Context.—: There is limited literature describing gynecologic adenocarcinomas involving the urinary bladder and potential diagnostic pitfalls.

Objective.

View Article and Find Full Text PDF

Background: Identifying determinants that can predict response to weight loss interventions is imperative for optimizing therapeutic benefit. We aimed to identify changes in DNA methylation and mRNA expression of a subset of target genes following dietary and surgical interventions in high-fat-diet (HFD)-induced obese rats.

Methods: Forty-two adult Wistar Han male rats were divided into two groups: control rats (n = 7) and obese rats (n = 28), fed a HFD for 10 weeks (t10).

View Article and Find Full Text PDF
Article Synopsis
  • Basaloid salivary gland neoplasm of uncertain malignant potential (B-SUMP) includes pleomorphic adenomas (PAs) and other neoplasms; PLAG1 immunocytochemistry (ICC) is being studied to help differentiate between these neoplasms.* -
  • In a study of 45 B-SUMP cytology aspirates, PLAG1 staining was positive in 29 cases (64%), primarily in PAs, and showed good sensitivity (87%) and specificity (86%) for identifying benign tumors.* -
  • The findings suggest that a strong PLAG1 positive result supports a benign diagnosis of PA, whereas PLAG1-negative or equivocal results indicate that the tumors should remain classified as B
View Article and Find Full Text PDF

Objective: Hyperintensity signal in T2-weighted magnetic resonance imaging (MRI) has been related to better therapeutic response during pasireotide treatment in acromegaly. The aim of the study was to evaluate T2 MRI signal intensity and its relation with pasireotide therapeutic effectiveness in real-life clinical practice.

Design, Patients And Measurements: Retrospective multicentre study including acromegaly patients treated with pasireotide.

View Article and Find Full Text PDF
Article Synopsis
  • ThyroSeq testing evaluates the risk of cancer in thyroid nodules classified as Bethesda category IV based on cytology, focusing on its association with specific molecular changes and overall malignancy risk.
  • The study analyzed 92 fine-needle aspirations (FNAC) from BIV nodules, identifying various subcategories like follicular neoplasm (FN) and oncocytic follicular neoplasm (OFN), revealing differences in malignancy risks and molecular alterations between them.
  • Findings showed that oncocytic follicular neoplasms had a lower malignancy risk and different molecular mutations compared to follicular neoplasms, indicating the need for subcategory differentiation in the assessment process.*
View Article and Find Full Text PDF

Unlabelled: Castration-resistant prostate cancer (CRPC) is fatal and therapeutically under-served. We describe a novel CRPC-restraining role for the vasodilatory soluble guanylyl cyclase (sGC) pathway. We discovered that sGC subunits are dysregulated during CRPC progression and its catalytic product, cyclic GMP (cGMP), is lowered in CRPC patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Between 2016 and 2022, males made up a larger percentage of interim chairs (66%) but females had a higher success rate of becoming permanent chairs (47% vs. 27%).
  • * The study surveyed interim chairs to identify gender differences but found no significant reasons for the advancement disparity, except that male interim chairs tended to be older than their female counterparts.
View Article and Find Full Text PDF

Introduction: Different medical therapies have been developed for pituitary adenomas. However, Non-Functioning Pituitary Neuroendocrine Tumors (NF-PitNET) have shown little response to them. Furthermore, epithelial-mesenchymal transition (EMT) has been linked to resistance to medical treatment in a significant number of tumors, including pituitary adenomas.

View Article and Find Full Text PDF

Over the course of the COVID-19 pandemic, SARS-CoV-2 variants of concern (VOCs) with increased transmissibility and immune escape capabilities, such as Delta and Omicron, have triggered waves of new COVID-19 infections worldwide, and Omicron subvariants continue to represent a global health concern. Tracking the prevalence and dynamics of VOCs has clinical and epidemiological significance and is essential for modeling the progression and evolution of the COVID-19 pandemic. Next generation sequencing (NGS) is recognized as the gold standard for genomic characterization of SARS-CoV-2 variants, but it is labor and cost intensive and not amenable to rapid lineage identification.

View Article and Find Full Text PDF
Article Synopsis
  • Identifying metastatic breast carcinoma (mBC) in malignant effusion cytology (MEC) is crucial for assessing prognosis and treatment, and recent studies have highlighted TRPS1 as a promising marker for both primary and metastatic breast cancer.
  • The study analyzed 82 MEC specimens, comparing TRPS1 expression in mBC to metastatic carcinoma of Müllerian origin (mMC) and metastatic pulmonary adenocarcinoma (mPAC), finding that TRPS1 successfully identified mBC in 100% of cases but also showed significant expression in mMC.
  • While TRPS1 proves to be a sensitive marker for mBC, its expression in mMC poses a diagnostic challenge, suggesting that using a combination of immunoperoxidase panels
View Article and Find Full Text PDF

Context.—: Pseudocarcinomatous urothelial hyperplasia (PCUH) architecturally and cytologically mimics cancer. The urine cytology features of PCUH have not been described.

View Article and Find Full Text PDF